ConductScience.org, home

Paper40565232

Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions.

Guo M and 4 others. Int J Mol Sci, 2025. Cited by 3 papers, by iCite.

Cite this record

ConductScience Library. Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions. Papers, record 40565232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40565232

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Overview of Cellular Therapeutics Clinical Trials: Advances, Challenges, and Future Directions.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
3
iCite
Revised in PubMed
2025-06-28
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Guo MMeizhai
2Zheng BBingyi
3Zeng XXiaoling
4Wang XXueting
5Tzeng CMChi-Menghttps://orcid.org/0000-0003-3490-2574

Source PubMed

Download CSV of authors

Topics6

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell- and Tissue-Based TherapyMajor topic
Stem Cell TransplantationMajor topic
Humans
Clinical Trials as Topic
Medicine, Chinese Traditional
Animals

References134

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125126443Autologous bone marrow mononuclear cells intrathecal transplantation in chronic stroke.Stroke Res Treat2014https://conductscience.org/library/papers/25126443PubMed
218075415Assessment of intra-arterial injected autologous bone marrow mononuclear cell distribution by radioactive labeling in acute ischemic stroke.Clin Nucl Med2007https://conductscience.org/library/papers/18075415PubMed
324480430Intracerebral implantation of autologous peripheral blood stem cells in stroke patients: a randomized phase II study.Cell Transplant2014https://conductscience.org/library/papers/24480430PubMed
434738731Engineered Small Extracellular Vesicles as a FGL1/PD-L1 Dual-Targeting Delivery System for Alleviating Immune Rejection.Adv Sci (Weinh)2022https://conductscience.org/library/papers/34738731PubMed
523127560Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery.Cell Transplant2013https://conductscience.org/library/papers/23127560PubMed
630156755Autologous Endothelial Progenitor Cells Transplantation for Acute Ischemic Stroke: A 4-Year Follow-Up Study.Stem Cells Transl Med2019https://conductscience.org/library/papers/30156755PubMed
733036265Clinical Trials of Stem Cell Therapy for Cerebral Ischemic Stroke.Int J Mol Sci2020https://conductscience.org/library/papers/33036265PubMed
824304379Comprehensive health assessment and five-yr follow-up of allogeneic islet transplant recipients.Clin Transplant2013https://conductscience.org/library/papers/24304379PubMed
940447329Adapting for the future: what can we learn from REMAP-CAP and COVID-19 pandemic trials?Thorax2025https://conductscience.org/library/papers/40447329PubMed
1035856397Clinical and laboratory findings following transplantation of allogeneic adipose-derived mesenchymal stromal cells in knee osteoarthritis, a brief report.Connect Tissue Res2022https://conductscience.org/library/papers/35856397PubMed
1135120619iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders.Cell Stem Cell2022https://conductscience.org/library/papers/35120619PubMed
1230586746A Phase 2 Randomized, Sham-Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow-Derived ALD-401 Cells in Patients With Recent Stable Ischemic Stroke (RECOVER-Stroke).Circulation2019https://conductscience.org/library/papers/30586746PubMed
1333705413Clinical efficacy on glycemic control and safety of mesenchymal stem cells in patients with diabetes mellitus: Systematic review and meta-analysis of RCT data.PLoS One2021https://conductscience.org/library/papers/33705413PubMed
1424693196Autologous intravenous mononuclear stem cell therapy in chronic ischemic stroke.J Stem Cells Regen Med2012https://conductscience.org/library/papers/24693196PubMed
1540329337Bone marrow mesenchymal stem cells transport connexin43 via tunneling nanotubes to alleviate isopreterenol-induced myocardial hypertrophy.Stem Cell Res Ther2025https://conductscience.org/library/papers/40329337PubMed
1639967882Formation of self-assembly aggregates in traditional Chinese medicine decoctions and their application in cancer treatments.RSC Adv2025https://conductscience.org/library/papers/39967882PubMed
1740357115Safety and Efficacy of CD19-Targeted Chimeric Antigen Receptor (CAR) T-cells Generated Using DNA Transposon Systems: A Meta-Analysis.Cureus2025https://conductscience.org/library/papers/40357115PubMed
1840468398New discoveries in therapeutic targets and drug development pathways for type 2 diabetes mellitus under the guidance of precision medicine.Eur J Med Res2025https://conductscience.org/library/papers/40468398PubMed
1930064455
Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: long-term follow up of a multicenter randomized controlled clinical trial (phase I/II).
J Transl Med2018https://conductscience.org/library/papers/30064455PubMed
2034587879MiR-218-5p Mediates Myocardial Fibrosis after Myocardial Infarction by Targeting CX43.Curr Pharm Des2021https://conductscience.org/library/papers/34587879PubMed

See all 134 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.

PMIDTitleJournalYearIn PapersSource
42578174Knowledge and attitude of Malaysian university students towards regenerative medicine therapy and their clinical implications: a cross-sectional study.Front Genet2026https://conductscience.org/library/papers/42578174PubMed
41596012Bioengineered Cellular and Acellular Therapies for Ischemic Heart Disease in Clinically Relevant Models.Bioengineering (Basel)2026https://conductscience.org/library/papers/41596012PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
CXCR47852PubTator's text mininghttps://conductscience.org/library/genes/7852

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40565232

GET https://conductscience.org/api/papers/v1/40565232/references?page=2